Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth

van den Heuvel, A. Pieter J., Jing, Junping, Wooster, Richard F., Bachman, Kurtis E.·2012·Cancer Biology & Therapy

Cited by (215)

Items 101–200 of 215

  1. Endogenous glutamine decrease is associated with pancreatic cancer progression
    Cecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, Roberta Curto, Claudia Curcio, Valeria Catanzaro, Giuseppe Digilio, Sergio Padovan, Maria Paola Puccinelli, Monica Isabello et al. · 2017 · Oncotarget
  2. T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic Conditions
    Zeynep Sener, F. Henning Cederkvist, Roman Volchenkov, Halvor L. Holen, Bjørn Steen Skålhegg · 2016 · PLoS ONE
  3. Targeting Energy Metabolism in Cancer Treatment
    Joanna Kubik, Ewelina Humeniuk, Grzegorz Adamczuk, B Madej, Agnieszka Korga-Plewko · 2022 · International Journal of Molecular Sciences
  4. Metabolic Signaling Cascades Prompted by Glutaminolysis in Cancer
    Raj Shah, Suzie Chen · 2020 · Cancers
  5. Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment
    Maksymilian Baryła, Aleksandra Semeniuk-Wojtaś, Letycja Róg, Leszek Kraj, Maciej Małyszko, Rafał Stec · 2022 · Biology
  6. Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes
    Joo Young Kim, Sun‐Hee Heo, Seul Ki Choi, In Hye Song, In Ah Park, Young‐Ae Kim, Hye Seon Park, Suk Young Park, Won Seon Bang, Gyungyub Gong et al. · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  7. Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma
    Prahlad V. Raninga, Yaowu He, Keshava K. Datta, Xue Mei Lu, Uma R. Maheshwari, Pooja Venkat, Chelsea Mayoh, Harsha Gowda, Murugan Kalimutho, John David Hooper et al. · 2022 · Molecular Therapy
  8. Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells
    Ileana Hernández‐Reséndiz, Juan Carlos Gallardo‐Pérez, Ámbar López-Macay, Diana Xochiquetzal Robledo‐Cadena, Enrique Garcı́a-Villa, Patricio Gariglio, Emma Saavedra, Rafael Moreno‐Sánchez, Sara Rodríguez‐Enríquez · 2018 · Journal of Cellular Physiology
  9. Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
    Y. Romero, Arnoldo Aquíno-Gálvez · 2021 · International Journal of Molecular Sciences
  10. Warburg and Krebs and related effects in cancer
    Judith E. Unterlass, Nicola J. Curtin · 2019 · Expert Reviews in Molecular Medicine
  11. Mechanistic Basis of Glutaminase Activation
    Yunxing Li, Jon W. Erickson, Clint A. Stalnecker, William P. Katt, Qingqiu Huang, Richard A. Cerione, Sekar Ramachandran · 2016 · Journal of Biological Chemistry
  12. Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
    Liang Wang, Wen Peng, Tianming Wu, Pengchi Deng, Yinglan Zhao · 2018 · Cell Death Discovery
  13. Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach
    L. Rajasinghe, Melanie Hutchings, S. Gupta · 2019 · Metabolites
  14. Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer
    Chuanfan Zhong, Kaihui Wu, Shuo Wang, Zining Long, Taowei Yang, Weibo Zhong, Xiao Tan, Zixian Wang, Chuanyin Li, Jianming Lü et al. · 2021 · Cell Death and Disease
  15. Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes
    Tineke W.H. Meijer, Monika G. Looijen-Salamon, Jasper Lok, Michel M. van den Heuvel, Bastiaan B.J. Tops, Johannes H. A. M. Kaanders, Paul N. Span, Johan Bussink · 2019 · Thoracic Cancer
  16. Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models
    M. Raymond V. Finlay, Mark J. Anderton, Andrew Bailey, Scott Boyd, Joanna L. Brookfield, Ceri Cairnduff, Mark D. Charles, Anne Cheasty, Susan E. Critchlow, Janet D. Culshaw et al. · 2019 · Journal of Medicinal Chemistry
  17. Cancer metabolomics in basic science perspective
    Hyuk Nam Kwon, Sehyun Oh, Xing Jin, Yong An, Sunghyouk Park · 2015 · Archives of Pharmacal Research
  18. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression
    Shams S. M. Tabrez, Torki A. Zughaibi, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan, Azhar Ullah Khan · 2022 · Molecules
  19. 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell
    Xuanzhu Zhou, Wei Zheng, G. A. Nagana Gowda, Daniel Raftery, Shawn Scott Donkin, Brian J. Bequette, Dorothy Teegarden · 2016 · The Journal of Steroid Biochemistry and Molecular Biology
  20. Glutaminase inhibitors: a patent review
    Canrong Wu, Lixia Chen, Sanshan Jin, Hua Li · 2018 · Expert Opinion on Therapeutic Patents
  21. Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancer
    Wu-Xi Zhou, Chen Chen, Xiaoqin Liu, Ying Li, Yaolan Lin, Xiu-Tao Wu, Lingyi Kong, Jian‐Guang Luo · 2020 · European Journal of Medicinal Chemistry
  22. iTRAQ‐Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer
    Zhen Jiang, Chenghua Zhang, Li Gan, Yuewang Jia, Yu Chun Xiong, Yujiang Chen, Zhi Wang, Linfeng Wang, Hao Luo, Juexi Li et al. · 2018 · PROTEOMICS - CLINICAL APPLICATIONS
  23. A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapy
    Laura J. Pallett, Sarah Dimeloe, Linda V. Sinclair, Adam J. Byrne, Anna Schurich · 2021 · Immunotherapy Advances
  24. Identification and characterization of a novel glutaminase inhibitor
    Henning Cederkvist, Shrikant Shantilal Kolan, Jonas Aakre Wik, Zeynep Sener, Bjørn Steen Skålhegg · 2021 · FEBS Open Bio
  25. Targeting glutamine metabolism in myeloproliferative neoplasms
    Huichun Zhan, Kristen Ciano, Katherine Dong, Stanley Zucker · 2015 · Blood Cells Molecules and Diseases
  26. Nutritional Stress in Head and Neck Cancer Originating Cell Lines: The Sensitivity of the NRF2-NQO1 Axis
    Lidija Milković, Marko Tomljanović, Ana Čipak Gašparović, Renata Novak Kujundžić, Dina Šimunić, Paško Konjevoda, Anamarija Mojzeš, Nikola Đaković, Neven Žarković, Koraljka Gall‐Tros̆elj · 2019 · Cells
  27. Glutamine Transporter SLC1A5 Regulates Ionizing Radiation‐Derived Oxidative Damage and Ferroptosis
    Zhuhui Yuan, Tong Liu, Xiao Huo, Hao Wang, Junjie Wang, Lixiang Xue · 2022 · Oxidative Medicine and Cellular Longevity
  28. SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROS
    Federica Barreca, Michele Aventaggiato, Laura Vitiello, Luigi Sansone, Matteo Antonio Russo, Antonello Mai, Sérgio Valente, Marco Tafani · 2023 · Antioxidants
  29. Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression
    Kevinn Eddy, Mohamad Naser Eddin, Anna Fateeva, Stefano Vito Boccadamo Pompili, Raj Shah, Saurav Doshi, Suzie Chen · 2022 · Cells
  30. PET Imaging of 18F-(2S,4R)4-Fluoroglutamine Accumulation in Breast Cancer: From Xenografts to Patients
    Fei Liu, Xiaoxia Xu, Hua Zhu, Yan Zhang, Jianhua Yang, Lifang Zhang, Nan Li, Lin Zhu, Hank F. Kung, Zhi Yang · 2018 · Molecular Pharmaceutics
  31. Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis
    Zhongxiao Wang, Felix Yemanyi, Alexandra K. Blomfield, Kiran Bora, Shuo Huang, Chi‐Hsiu Liu, William R. Britton, Steve S. Cho, Yohei Tomita, Zhongjie Fu et al. · 2022 · eLife
  32. Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarction
    Erika Zodda, Olga Tura-Ceide, Nicholas L. Mills, Josep Tarragó‐Celada, M. Carini, Timothy M. Thomson, Marta Cascante · 2023 · eLife
  33. Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
    Sarkadi, Balazs, Meszaros, Katalin, Krencz, Ildiko, Canu, Letizia, Krokker, Lilla, Zakarias, Sara, Barna, Gabor, Sebestyen, Anna, Papay, Judit, Hujber, Zoltan et al. · 2020 · Cancers
  34. A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer
    Sandra Kannampuzha, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Reshma Murali, Arunraj Namachivayam, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Harishkumar Madhyastha et al. · 2023 · Vaccines
  35. Role and therapeutic targeting of glutamine metabolism in non‑small cell lung cancer (Review)
    Lei Zhou, Qi Zhang, Qing Zhu, Yuan Zhan, Yong Li, Xuan Huang · 2023 · Oncology Letters
  36. An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma
    Jianguo Bai, Ruifeng Tang, Keyu Zhou, Jialei Chang, Hongyue Wang, Qixin Zhang, Jiahui Shi, Chao Sun · 2022 · BMC Medical Genomics
  37. Influence of Serum and Hypoxia on Incorporation of [14C]‐ d ‐Glucose or [14C]‐ l ‐Glutamine into Lipids and Lactate in Murine Glioblastoma Cells
    Nathan L. Ta, Thomas N. Seyfried · 2015 · Lipids
  38. Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase
    Kaiyin Yang, Canrong Wu, Mengzhu Zheng, Ruotian Tang, Xingzhou Li, Li-Xia Chen, Hua Li · 2019 · Bioorganic Chemistry
  39. Identification of informative genes and pathways using an improved penalized support vector machine with a weighting scheme
    Weng Howe Chan, Mohd Saberi Mohamad, Safaai Deris, Nazar Zaki, Shahreen binti Kasim, Sigeru Omatu, Juan M. Corchado, Hany Alashwal · 2016 · Computers in Biology and Medicine
  40. FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma
    Tianyu Han, Pengcheng Wang, Yanan Wang, Wenze Xun, Jiapeng Lei, Tao Wang, Zhuo Lü, Mingxi Gan, Wei Zhang, Bentong Yu et al. · 2021 · Autophagy
  41. Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators
    Clint A. Stalnecker, Jon W. Erickson, Richard A. Cerione · 2017 · Journal of Biological Chemistry
  42. Therapeutic Potential of Glutamine Pathway in Lung Cancer
    Enyu Tang, SiYang Maggie Liu, Zhiming Zhang, Rixin Zhang, Dejing Huang, Tong Gao, Tianze Zhang, G Xu · 2022 · Frontiers in Oncology
  43. Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities
    Jossimar Coronel-Hernández, Eloy Andrés Pérez-Yépez, Izamary Delgado-Waldo, Carlos Contreras-Romero, Nadia Judith Jacobo-Herrera, David Francisco Cantú-De León, Carlos Pérez‐Plasencia · 2021 · Frontiers in Oncology
  44. Intratumoral heterogeneity of glutaminase and lactate dehydrogenase A protein expression in colorectal cancer
    Yuta Mizuno, Kimiaki Hattori, Kohei Taniguchi, Keitaro Tanaka, Kazuhisa Uchiyama, Yoshinobu Hirose · 2020 · Oncology Letters
  45. An updated patent review of glutaminase inhibitors (2019–2022)
    Danni Wang, Xiaohong Li, Guangyue Gong, Yulong Lu, Ziming Guo, Rui Chen, Huidan Huang, Zhiyu Li, Jinlei Bian · 2023 · Expert Opinion on Therapeutic Patents
  46. Two Faces of Glutaminase GLS2 in Carcinogenesis
    Joanna Buczkowska, Monika Szeliga · 2023 · Cancers
  47. Expression of Metabolism-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma
    Ja Seung Koo, Jin Sook Yoon · 2015 · American Journal of Clinical Pathology
  48. Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways
    Jennifer Fazzari, Katja Linher‐Melville, Gurmit Singh · 2016 · Current Neuropharmacology
  49. Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer Progression
    Kun Wang, Jingzhuo Li, Hai Zhang, Hongyan Ma, Hong‐Yong Cui, Huai‐Qiang Ju, Jing Zhang, Qing-zhi Ma, Ming Zhao, Qing-mei Zeng et al. · 2025 · Cancer Research
  50. Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines
    Kamal Eltayeb, Roberta R Alfieri, Claudia Fumarola, Mara A. Bonelli, Maricla Galetti, Andrea Cavazzoni, Graziana Digiacomo, Francesca Galvani, Federica Vacondio, Alessio Lodola et al. · 2024 · Biochemical Pharmacology
  51. High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding
    Thuy‐Tien T. Nguyen, Sekar Ramachandran, Matthew J. Hill, Richard A. Cerione · 2022 · Journal of Biological Chemistry
  52. Mitochondrial substrates in cancer: Drivers or passengers?
    Björn Kruspig, Boris Zhivotovsky, Vladimir G. Gogvadze · 2014 · Mitochondrion
  53. Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
    Friederike Steifensand, Julia K. S. Gallwas, Gerd Johannes Bauerschmitz, Carsten Gründker · 2021 · Cells
  54. Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma
    Xulu Ye, Qiliang Zhou, Yoshifumi Matsumoto, Masato Moriyama, Shun Kageyama, Masaaki Komatsu, Seijirou Satoh, Masanori Tsuchida, Yasuo Saijo · 2016 · Anticancer Research
  55. Sijunzi Tang improves gefitinib resistance by regulating glutamine metabolism
    Zhihong Wang, Taifeng Li, Ruisheng Li, Bo Cao, Shiyuan Wang, Xiaofei Fei, Chunyu Li, Guohui Li · 2023 · Biomedicine & Pharmacotherapy
  56. Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model
    Ryo Miyamoto, Hidehiko Takigawa, Ryo Yuge, Daisuke Shimizu, Misa Ariyoshi, Rina Otani, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Yuichi Hiyama et al. · 2024 · Experimental and Molecular Pathology
  57. N-terminal phosphorylation of glutaminase C decreases its enzymatic activity and cancer cell migration
    Carolline Fernanda Rodrigues Ascenção, Raghavendra Sashi Krishna Nagampalli, Zeyaul Islam, Matheus Pinto Pinheiro, Larissa Menezes dos Reis, Bianca Alves Pauletti, Carolina Aparecida de Guzzi Cassago, Daniela C. Granato, Adriana Franco Paes Leme, Sandra Martha Gomes Dias · 2018 · Biochimie
  58. Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1
    Guangzhao Zhu, Fangxia Guan, Shenglei Li, Qing Hua Zhang, Xueying Zhang, Yue Qin, Zhangzhan Sun, Shaohua Peng, Jiexing Cheng, Yiyang Li et al. · 2024 · Molecular Carcinogenesis
  59. Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy
    Luyuan Li, Josiane E. Eid, Ana Cristina Paz, Jonathan C. Trent · 2017 · BioDrugs
  60. Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration
    Yuju Li, Justin Peer, Runze Zhao, Yinghua Xu, Beiqing Wu, Yi Wang, Changhai Tian, Yunlong Huang, Jialin Zheng · 2017 · Translational Neurodegeneration
  61. Canceromics Studies Unravel Tumor’s Glutamine Addiction After Metabolic Reprogramming
    Javier Márquez, José Manuel Matés, Francisco José Alonso, Mercedes Martín‐Rufián, Carolina Lobo, José Angel Campos-Sandoval · 2015 · Springer eBooks
  62. Glutaminase 1 in mandarin fish Siniperca chuatsi: Molecular characterization, expression pattern and function involving in virus replication
    Shangui Liu, Ningqiu Li, Qiang Lin, Lihui Liu, Yinjie Niu, Hongru Liang, Zhibin Huang, Xiaozhe Fu · 2020 · Aquaculture
  63. Lifting the veil on tumor metabolism: A GDH1-focused perspective
    Sisi Zhou, Huaer Wu, Yun Chen, Jiawei Lv, Shufang Chen, Hua Yu, Tiezhu Shi, Xiongjun Wang, Lingyun Xiao · 2025 · iScience
  64. A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer
    Yanan Wang, Tianyu Han, Mingxi Gan, Meng Guo, Caifeng Xie, Jiangbo Jin, Song Zhang, Pengcheng Wang, Jiaqing Cao, Jian-Bin Wang · 2019 · Cell Cycle
  65. Stable isotope-resolved metabolomics analyses of metabolic phenotypes reveal variable glutamine metabolism in different patient-derived models of non-small cell lung cancer from a single patient
    Connor Jarrett Kinslow, Michael Bousamra ll, Yihua Cai, Jun Yan, Pawel Konrad Lorkiewicz, Ahmad Al‐Attar, Jinlian Tan, Richard M. Higashi, Andrew N. Lane, Teresa W.‐M. Fan · 2024 · Metabolomics
  66. CB-839 induces reversible dormancy in lung tumor-cells
    Azemat Jamshidi‐Parsian, Samir V. Jenkins, Amy Tran, Anna Bragg, Rylie Davis, Connor Griffin, Eric R. Siegel, Ruud P.M. Dings, Robert J. Griffin, Gunnar Boysen · 2024 · European Journal of Pharmacology
  67. circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway
    Changpeng Sun, Hongjun Guan, Jinjin Li, Yinfeng Gu · 2023 · Open Medicine
  68. Co-treatment with melatonin and ortho-topolin riboside reduces cell viability by altering metabolic profiles in non-small cell lung cancer cells
    Ji‐Won Lee, Hwanhui Lee, Soon-Wook Noh, Hyung‐Kyoon Choi · 2024 · Chemico-Biological Interactions
  69. Glutamine metabolism in the proliferation of GS-expression pituitary tumor cells
    Jintao Hu, Qingbo Chen, Xiao Ding, Xin Zheng, Xuefeng Tang, Song Li, Hui Yang · 2020 · Endocrine Connections
  70. Metabolic targeting of malignant tumors: a need for systemic approach
    Aggelos T. Margetis · 2022 · Journal of Cancer Research and Clinical Oncology
  71. Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.
    Cindy E Jiménez-Ávila, Vanessa Villegas-Ruíz, Marta Zapata‐Tarrés, Alejandra Elizabeth Rubio-Portillo, Eleazar I Pérez López, Juan Carlos Zenteno, Sergio Juárez‐Méndez · 2018 · Europe PMC (PubMed Central)
  72. Glutaminase 1 inhibitors: Therapeutic potential, mechanisms of action, and clinical perspectives
    Hui Wang, Xiandeng Li, Haitao Hu, Zhan Gao · 2025 · Biochemical Pharmacology
  73. Pathway metabolite ratios reveal distinctive glutamine metabolism in a subset of proliferating cells
    Nancy T. Santiappillai, Yue Cao, Mariam F. Hakeem-Sanni, Jean Yee Hwa Yang, Lake‐Ee Quek, Andrew J. Hoy · 2025 · Molecular Systems Biology
  74. Structure-based virtual screening discovers novel kidney-type glutaminase inhibitors
    Li-Chun Lin, Hsin‐Yi Chang, Tony Eight Lin, Jyh-Ruey Lin, Shih‐Min Hsia, Kai‐Cheng Hsu, Tsui‐Chin Huang · 2022 · Biomedicine & Pharmacotherapy
  75. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform
    Monika Szeliga, Jarosław Bogdan Ćwikła, Marta Obara‐Michlewska, Andrzej S Cichocki, Jan Albrecht · 2015 · Experimental and Molecular Pathology
  76. c‐MYC mRNA tail tale about glutamine control of transcription
    Chi Van Dang · 2017 · The EMBO Journal
  77. Metabolic Responses of Lung Adenocarcinoma Cells to Survive under Stressful Conditions Associated with Tumor Microenvironment
    Ángeles Carlos‐Reyes, Susana Romero‐Garcia, Heriberto Prado-Garcı́a · 2024 · Metabolites
  78. Silencing of miR-23a attenuates hydrogen peroxide (H2O2) induced oxidative damages in ARPE-19 cells by upregulating GLS1: an in vitro study
    Yang Zhou, Meilibanu Yusufu, Ting Zhang, Jing Wang · 2020 · Cytotechnology
  79. Reduced Usage of GLS Intronic Polyadenylation Promotes Cellular Senescence
    Xueping Li, Yuxin Li, Dong Ding, Baiyun Xie, Jun Yao, Yu Chen, Zhaozhao Zhao, Peng Yu, Shengwei Zhang, Yang Fu et al. · 2025 · Phenomics
  80. Glutaminase I and glutamine transaminase–ω-amidase pathways in colorectal cancer: Metabolic reprogramming and emerging therapeutic strategies
    Sarah F Voor, Arthur J.L. Cooper, John Thomas Pinto · 2025 · Analytical Biochemistry
  81. Genetic estimation of correlations between circulating glutamine and cancer.
    Kai Zhang, Hongjin Liang · 2023 · PubMed Central
  82. The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism?
    Roxana Simona Redis, George A. Călin · 2016 · Molecular & Cellular Oncology
  83. Micromonosporamide A with Glutamine-Dependent Cytotoxicity from Micromonospora sp. MM609M-173N6: Isolation, Stereochemical Determination, and Synthesis
    Toshifumi Takeuchi, Masaki Hatano, Hideyuki Muramatsu, Yumiko Kubota, Ryûichi Sawa, Masayuki Igarashi · 2021 · Organic Letters
  84. Integration of single-cell RNA-seq data into metabolic models to characterize tumour cell populations
    Chiara Damiani, Davide Maspero, Marzia Di Filippo, Riccardo Colombo, Dario Pescini, Alex Graudenzi, Hans Victor Westerhoff, Lilia Alberghina, Marco Vanoni, Giancarlo Mauri · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Mitochondrial Metabolomics in Cancer: Mass Spectrometry-Based Approaches for Metabolic Rewiring Analysis and Therapeutic Discovery
    Yuqing Gao, Zhirou Xiong, Xinyi Wei · 2025 · Metabolites
  86. Association between GLS Gene Polymorphisms and the Susceptibility to Lung Cancer in the Chinese Han Population
    Yuhe Wang, Mingyue Chen, Faling Yi, Jinpeng Xu, Changchun Liu, Ziyi Zhang, Ping Wang, Tianbo Jin, Mingwei Chen · 2023 · Frontiers in Bioscience-Landmark
  87. The Bioenergetic Role of Mitochondria in Lung Cancer
    Keely E. FitzGerald, Purna Chaitanya Konduri, Chantal Vidal, Hyuntae Yoo, Zhang Li · 2017 · InTech eBooks
  88. Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
    Claudia Tanja Mierke · 2020 · Biological and medical physics, biomedical engineering
  89. L-5-[11C]-glutamine PET of breast cancer: Preclinical studies in mouse models
    Christopher Hensley, Prashanth K. Padakanti, R. Damani, C. Dulal, Hoon Choi, Shi-Hong Li, Jianbo Cao, Hsiao-Ju S. Lee, A. Pantel, Elizabeth J. Li et al. · 2025 · Nuclear Medicine and Biology
  90. WTAP-Mediated Glutaminase Splicing Bias Suppresses Ferroptosis in Hepatocellular Carcinoma
    Can Zhu, Ke Wu, Ke Wu, Jun Ma, Bo Ding, Nan Jiang, Keyi Du, Guomin Ju, Haiyang Xie, Chuanhui Peng et al. · 2026 · 癌症:英文版
  91. The Interplay of Splicing and Metabolism in Cancer
    Dillon M. Voss, Yange Cui, Peter S. Klein · 2026 · Cells
  92. Illuminating spatial dynamics of glutamine metabolism with a sensitive genetically encoded biosensor
    Jack M. Scully, Michael J Sun, Siddarth Das, Nataly J. Arias, Edmund D. Kapelczak, Tiffany D. Robinson, Katie G. Vineall, Teagan S. Dean, Tara A. TeSlaa, Ajit S. Divakaruni et al. · 2026 · RSC Chemical Biology
  93. A Local-Network Guided Linear Discriminant Analysis for Classifying Lung Cancer Subtypes using Individual Genome-Wide Methylation Profiles
    Yanming Li · 2019 · Advances in intelligent systems and computing
  94. Lung Tumors
    Helmut Popper · 2021 · Springer eBooks
  95. Clinical and biological impact of SNAT7 in lung adenocarcinoma: implications for prognosis and treatment
    Asato Hashinokuchi, Naoki Haratake, Yuya Ono, Takumi Tomonaga, Giacomo Bassi, Kyoto Matsudo, Fumihiko Kinoshita, Taichi Matsubara, Mikihiro Kohno, Tomoyoshi Takenaka et al. · 2025 · International Journal of Clinical Oncology
  96. Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switching
    Seungyeon Yang, Minbeom Ko, Wei Zhang, Seung Min Jeong · 2025 · Biochemical and Biophysical Research Communications
  97. Exosomes loaded with metabolites: Roles in crosstalk between tumor cells and their microenvironment
    Ping Ye, Mingjun Sun, Jia Wang, Xianzhao Bai, Zihan Li, Qiang Lin, Ran Liu · 2025 · European Journal of Pharmacology
  98. Structural reassignment of compound 968, an allosteric glutaminase inhibitor
    Lindsey Albertelli, Sainabou Jallow, Chun Li, Scott Michael Ulrich · 2026 · Beilstein Journal of Organic Chemistry
  99. Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAs
    Yuwei Feng, Xiaowei Sun, Tiangu Yang, Jingqi Han, Dapeng Zhou, Haitao Ren, Yulong Sheng, Yanhua Wang · 2022 · Computational and Mathematical Methods in Medicine · Retracted
  100. Sijunzi Tang Enhances The Sensitivity of Lung Cancer Cells To Gefitinib Based On Glutamine Metabolism
    Zhihong Wang, Shiyuan Wang, Xia Liu, Bo Cao, Mingyu Zhang, Chunyu Li, Guohui Li · 2021 · Research Square